N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs

Pulmonary Pharmacology and Therapeutics

Volumn 12, Issue 6, 1999, Pages 369-375

  Nawrocka, A ^a   Papierz, W ^a   Bialasiewicz, P ^a   Stolarek, R ^a   Komos, J ^a   Nowak, D ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Ambroxol; Endotoxin; Lipopolysaccharide; Lung damage; N acetylcysteine; Phagocyte influx

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ENDOTOXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOPOLYSACCHARIDE; LUMINOL; REACTIVE OXYGEN METABOLITE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL SUSPENSION; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG ALVEOLUS; LUNG BLOOD VESSEL; MACROPHAGE; MALE; MICROVASCULATURE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RAT;

EID: 0033396902     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0219     Document Type: Article

References (31)

1. Brigham K., Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 133:1986;913-927.
2. Thommasen H., Russel J., Boyko W., Hogg J. Transient leukopenia associated with adult respiratory distress syndrome. Lancet. 14:1984;809-812.
3. Uchiba M., Okajima K., Murokami K., Okabe H., Takatsuki K. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res. 78:1995;117-125.
4. Mathison J., Tobias P., Wolfson E., Ulevitch R. Plasma lipopolysaccharide (LPS)-binding protein. J Immunol. 149:1992;200-206.
5. Schlichting E., Aspelin T., Lyberg T. Interactions of endotoxin with human blood cells and serum proteins. Scand J Clin Invest. 56:1996;167-176.
6. Barton P., Warren J. Complement component C5 modulates the systemic Tumor Necrosis Factor response in murine endotoxic shock. Infect Immun. 61:1993;1474-1481.
7. Neugebauer E., Holaday J. Handbook of mediators in septic shock. CRC Press. 1993.
8. Quezado Z., Hoffman W., Winkelstein J. The third component of Complement protects against E. coli endotoxin-induced shock and multiple organ failure. J Exp Med. 179:1994;569-578.
9. Lewis J., Veldhuizen R., Possmayer F. Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep. Am J Respir Crit Care Med. 150:1994;123-130.
10. Petrone W. F., English D. K., Wong K., McCord J. M. Free radicals and inflammation. Superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA. 77:1980;1159-1163.
11. Gillissen A., Nowak D. Characterisation of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med. 92:1998;609-623.
12. Lapenna D., Gioia S., Ciofani G., Cuccurullo F. Ambroxol is a scavenger of hypochlorus acid and monochloramine. Pharmacology. 49:1994;132-135.
13. Nowak D, Antczak A., Pietras T., Bialasiewicz P, Krol M. Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice. Eur Respir J. 7:1994;1629-1634.
14. Nowak D. Ambroxol - mucolitic drug or antioxidant too? Sense. 1995.
15. Nowak D., Pietras T., Antczak A., Krol M., Piasecka G. Ambroxol inhibits endotoxin-induced lipid peroxidation in mice. Pol J Pharmacol. 45:1993;317-322.
16. Nowak D., Pietras T., Antczak A., Krol M., Piasecka G. Effect of bacterial lipopoly-saccharide on the content of lipid peroxidation products in lungs and other organs of mice. Int J Gen M. 63:1993;77-83.
17. Stetkiewicz J. Utility of morphometric analysis in estimation of toxity of chemical substances. Institute of Occupational Medicine. 1991.
18. ZielinÂski K. Outline of principles in histomorphometry used for investigations in pathology. Pol J Pathol. 45 (Suppl):1994;4.
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 97 (Suppl):1968;77.
20. Blue M., Janoff A. Possible mechanisms of emphysema in cigarette smokers. Release of elastase from human polymorphonuclear leukocytes by cigarette smoke condensate in vitro. Am Rev Respir Dis. 117:1978;317-325.
21. Shi M., Godleski J., Paulauskis J. Regulation of macrophage inflammatory protein 1- α mRNA by oxidative stress. J Biol Chem. 271:1996;5878-5883.
22. Buttke T., Sandstrom P. Oxidative stress as a mediator of apoptosis. Immunology Today. 15:1994;7-10.
23. Droge W., Eck H., Gmunder H., Mihm S. Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivates. Am J Med. 91 (Suppl 3C):1991;3C140S-3C144S.
24. Hoffer E., Baum Y., Tabak A., Taitelman U. N-acetylcysteine increase the glutatione content and protects rat alveolar type II cells against paraquat-induced cytotoxity. Toxicol Letters. 84:1996;7-12.
25. MacNee W., Bridgeman M., Marsden M., Drost E., Lannan S., Selby C., Donaldson K. The effects of N-acetylcysteine and glutatione on smoke-induced changes in lung phagocytes and epithelial cells. Am J Med. 91 (Suppl 3C):1991;3C60S-3C66S.
26. Bernard G. N-acetylcysteine in experimental and clinical acute lung injury. Am J Med. 91 (Suppl 3C):1991;3C54S-3C59S.
27. Meyer A., Buhl R., Kampf S., Magnussen H. Intravenous N-acetylcysteine and lung glutatione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med. 152:1995;1055-1060.
28. Sciuto A., Strickland P., Kennedy T., Gurtner G. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med. 151:1995;768-772.
29. Forman M., Puett D., Cates C., McCroskey D., Beckman J., Green H., Virmani R. Glutatione redox pathway and reperfusion injury. Circulation. 78:1988;202-213.
30. Bast A., Haenen G., Doelman C. Oxidants and antioxidants: state of art. Am J Med. 91 (Suppl 3C):1991;3C2S-3C13S.
31. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 91 (Suppl 3C):1991;3C14S-3C22S.